Howard Halpern to Prospective Studies
This is a "connection" page, showing publications Howard Halpern has written about Prospective Studies.
Connection Strength
0.004
-
Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: preliminary results of a randomized, open-labeled, phase II trial. Int J Radiat Oncol Biol Phys. 1993 Jul 15; 26(4):721-9.
Score: 0.004